Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I think it’s still BS on the company and just highlights their lack of competence with sales and marketing. Many of us at some point have pointed out to the company flaws and mistakes in strategy or materials used in promotions. If the FDA messed with them they could just beat them again in court. This is all about a company that only had a plan to sell itself for full price and got stuck because of Nevada. They can do plenty in the short term to improve their value but still sit there looking into headlights waiting on SCOTUS. Not impressed so far with the new guy.
This is a very easy ballot:
1). NO
2). NO
3). HELL NO
4). For
Must be out of the GS office in Hong Kong to help the Chinese government attempt a buyout on the cheap. Now there is a good rumor....lol.
I agree BS on the generic too, never heard a doctor mention anything other than the brand name.
If I find a list I will send it over. I should have time to look for it this weekend.
If we can find a list I will be happy to email a few managers.
Pass the word.... we can call it the 150 million share March to Amarin board reform. Vote No
We can send a message with our proxy statement by cleaning house. I voted no to everything but the auditors. If someone has contact info for the funds that hold Amarin I will gladly help reach out to solicit a no vote.
I think this might be a requirement with this type of litigation. If Teva ruling comes out soon we might see some movement with settlement. If you’re Healthnet you are crazy if you don’t settle.
I think all they have to do, the pharmaceutical industry is put out a public service announcement that simply points out if the IP is stolen during the next health crisis the US will be the last to get the vaccine or therapeutic out of fear it will be stolen. You can kiss their seats good bye and that message will scare more than defund the police.
He can talk all he wants but it’s not going to happen. How about just sending all of our supply to the needy countries? Think that would play well in the press? I don’t think India is a third world country and what is happening there is awful. But, how does stealing US IP help them? They can clearly afford to buy vaccines.
Terrible how we will waste away as a country for the next 4 years and can only pray we elect someone normal. At least you have a couple of Democratic Senators not willing to drink the Jonestown kool-aid.
I can play your game to, Your Wrong!
Hope your short does not work out.
We will see, if it does not happen by year end then you are probably right and probably means a big pharmaceutical is not interested.
It is basic math, you start with a price of zero.....what is the price the EU will approve? Then you can run your sales model.
We are not going to agree on this point. I say all the risk is on the acquirer without a known EU price. No offer will be made until most of the risk is removed.
If you are the buyer how do you set the offer without an idea of the revenue stream? If you are Amarin, how do you accept an offer without knowing it’s fair compared to the potential revenue. I would agree with you if we had the US market. The offer could price US peak plus EU. Now the buyout had to be EU peak plus the US. Can’t come up with that without the prescription price and you don’t buy it without and assume all the risk. So, we wait.
I don’t think we languish for years, while we all believe this company lacks competence I really believe it comes from a lack of staff. I believe they hired the bare minimum and just needed to get some sales momentum until they could have defended patents or settlements in place plus EU approval for maximum offer. Du put a halt to that plan. To get maximum price they needed full US market plus Europe to remove risk to the buyer. Now I believe to get a better, albeit lower price they need EU pricing in place to determine the buyout value. I see a buyout after EU pricing. They really are not staffing the company as a GIA entity capable of generating billions. If we see a huge ramp with staff positions across all operations then I will be concerned.
No problem, I found lots of errors and to me it’s a typical bash piece to push down the price.
I don’t think they will be able to pull it off and they can talk all they want. It would not surprise me if some of their wall street buddies went short on biotechnology and asked them to do this. Think of all the money they are making. If it ever got further than the media sound bite all Pfizer has to say is when the next health crisis or pandemic hits, we will develop the drug in the country that we know will protect our IP. That will end the debate.
Another road to go is what BB has talked about regarding the takings clause of the constitution and I would think the courts might stop the government from doing this since the health crisis is not in the US.
See this post: 338715
Anyone know the current short interest, sure looks like they want to pound it into the ground. Even that last article is a hit piece. This is really some big money taking advantage of a company that lacks a short term catalyst.
Good to see the Canadians begin to show revenue growth and with reimbursement now kicking in maybe we can see a jump in scripts of tens of thousands a quarter.
It may not be needed to get approval but perhaps required post approval. I just don't see the FDA saying no on a positive outcome, conducted by the VA against a disease with so few options. Then again, if we don't resolve the patent problems I don't see them adding it to the US label. The ROW will benefit from additional indications.
Colon cancer and Alzheimer’s trials are scheduled to conclude in November and imagine what would happen if the Alzheimer’s results are positive.
Maybe it has something to do with the capsule. I just checked my bottle of Vascepa refill from last week and the expiration date is 5/2024.
Actually if you have the right insurance you are paying $3.00 per month for a 90 day supply.
So in 2013 she let a slaughter go through and then in 2015 she ruled against another. Talk about inconsistencies but I guess I can’t use it.
Perfect, she now has another title to go along with judge, horse slaughterer. I am going to see if I can post this on some horse lover sites and tie in Amarin.
This is sad, as someone who had horses as a kid when you take care of them, treat them well it’s like having a thousand pound dog you can ride. Best exercise with so much enjoyment but plenty of work involved in owning a horse.
Can the poster who shared the link of the article where Du sentenced the horses to die please repost. I want to share it across Twitter.
I would think the news media would pick up on this if we phrase it a way how it impacts multiple areas of American life. Here, you can defraud our courts as long as it fits a radical and irrational agenda. What is at stake:
US leadership in high tech and biotechnology
The loss of STEM careers for our children
Loss of breakthrough technology and medicines
When it comes to the loss in biotechnology leadership quality of life declines and possibly longevity
All thanks to the horse killer judge Miranda Du.
Again the strategy is an appeal, the hope is that the appeals court will take fraud seriously.
maybe you missed it....there is a plan and one can HOPE it works.
Let’s hope this time an appeal works and it makes her look foolish. I can’t imagine an appeals court would be ok with fraud because of a technicality.
What would you expect from a horse murderer which kinda goes against the whole PITA lefty agenda. I still think she did not rule along partisan lines. It’s a narcissistic need to have a case precedent of the Du standard for obviousness. That’s why she will fight against any action to reverse her ruling. I just pray SCOTUS puts her in her place on this.
Let me chat with the band to see how we can line up another fundraiser and the logistics of getting this done.
Maybe it’s time to take the fight to another level. If Amarin will not do a lab analysis comparing v to GV maybe we should. We can measure amount of EPA, DHA (if any) fillers and the percentage and the percentage of oxidation. Use a reputable lab and publish the results if we find what we believe is a large amount of oxidation and fillers. We can each send the results to the FDA, state AG, better business bureau and congressional representatives. Also send a copy to Du thanking her for her contributions to hurting those forced to take GV.
Hope your right and the first hurdle is they take the case.
I thought our chances were zero with SCOTUS but now I think we have a slim chance they pick it up. Guess we will know in about a month.
It’s our last hope, if SCOTUS takes the case our chances of winning will be better than 50% given recent rulings and strict interpretation of statute.
This is a really good reply and if you read between the lines it does not suggest GIA is the ultimate strategy. They were looking at maximum value and you don’t get that without eliminating the unknowns. First was locking up the US market with tested patents or settlements. Next, European prices set which gets you to full value and eliminates the risk. Right now we are just full of risk and stuck waiting on the courts and the EU regulators.
While I think the world of Marjac I think BB is the better choice, we want him to drive the board to quit .
I know based on the bylaws we missed the deadline to add a shareholder proposal. Our next step is to vote against any proposals that we believe dilute our value. If they want to add shares to the employee incentive plan that will be a big NO.
Thanks and it’s so sad how our courts are just ruining the future for our children.